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The development of the hematopoietic system during early embryonic stages
occurs in spatially and temporally distinct waves. Hematopoietic stem cells
(HSC), the most potent and self-renewing cells of this system, are produced in
the final ‘definitive’ wave of hematopoietic cell generation. In contrast to
HSCs in the adult, which differentiate via intermediate progenitor populations
to produce functional blood cells, the generation of hematopoietic cells in the
embryo prior to HSC generation occurs in the early waves by producing blood
cells without intermediate progenitors (such as the ‘primitive’ hematopoietic
cells). The lineage relationship between the early hematopoietic cells and the
cells giving rise to HSCs, the genetic networks controlling their emergence,
and the precise temporal determination of HSC fate remain topics of intense
research and debate. This Review article discusses the current knowledge on
the step-wise embryonic establishment of the adult hematopoietic system,
examines the roles of pivotal intrinsic regulators in this process, and raises
questions concerning the temporal onset of HSC fate determination.
Keywords: embryo; endothelial-to-hematopoietic cell transition; ES cell
differentiation; Gata2; hematopoietic development; hematopoietic stem
cells; hematopoietic progenitor cells; HSC fate; Runx1
The adult hematopoietic system consists of a hierarchy
of cells that progress from a stem cell state to the termi-
nally differentiated cells of over 10 blood cell lineages.
While hematopoietic stem cells (HSC) are rare, long-
lived and self-renewing, there are many intermediate
progenitor cell types that in a stepwise manner, lose
their multi-lineage and self-renewing potency before
becoming mature functioning blood cells. Much is
known about the adult hematopoietic hierarchy, but
only recently do we begin to know the variety of
hematopoietic cells in the embryo and to understand
how they relate to the establishment of the adult
hierarchy and HSCs. In this review we discuss the cur-
rent knowledge on the embryonic development of the
adult hematopoietic system focusing on endothelial-to-
hematopoietic cell transition (EHT), and on some of the
pivotal transcriptional regulators and their targets
involved in this process, and in the generation of HSCs.
Hematopoiesis is initiated by transient
generation of primitive cells
Blood cells are one of the first differentiated cell/tissue
lineages generated in the vertebrate embryo.
Abbreviations
AGM, aorta-gonad-mesonephros; BL-CFC, blast colony-forming progenitor cells; CFU-C, colony-forming unit-cell; CFU-S, colony-forming unit-
spleen; EHT, endothelial-to-hematopoietic cell transition; EMP, erythroid–myeloid progenitors; ES, embryonic stem; FL, fetal liver; Gpr56, G
protein-coupled receptor 56; HE, hemogenic endothelial; HSC, hematopoietic stem cells; IAHC, intra-aortic hematopoietic cluster cells; UA,
umbilical arteries; VA, vitelline arteries; Vec, vascular endothelial-cadherin; YS, yolk sac.
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Surprisingly, they are produced even before the circula-
tion is established [1]. Transient waves of hematopoietic
cell production are first initiated extraembryonically in
the yolk sac (YS) blood islands (Fig. 1) [2] which are
derived from mesodermal cells that migrate to the YS
at neural plate stage. At embryonic day 7 (E7), the
mesodermal aggregates generate the first blood cells
[2,3]. The emergence of blood cells in the YS is in close
relationship with the appearance of endothelial cells
that form the first vascular structures. This spatiotem-
poral association between the emergence of hematopoi-
etic and endothelial cells has led to the hypothesis that
they arise from a common bipotential ancestor, which
is termed the hemangioblast [1].
The first genetic evidence supporting a common pre-
cursor for hematopoietic and endothelial lineages came
from deletion of the Flk1 receptor tyrosine kinase gene
in the mouse. Flk1 expression is detected as early as at
E7 in the YS mesoderm [4]. Embryos lacking Flk1 are
not viable and interestingly, show a complete absence
of mesodermal cell aggregates in the YS. It was con-
cluded that Flk1 is required for mesodermal cell migra-
tion to form YS blood islands and for making
hematopoietic and endothelial cells, [5] thus suggesting
that a bipotential hemangioblast generates hematopoi-
etic and endothelial cells. Intriguingly, lineage mark-
ing/tracing experiments have shown that there is little/
no overlap in the mesodermal precursors that are
forming the endothelial and hematopoietic cells in
individual blood islands, suggesting a segregation in
fate early before migration to the YS [6].
Mouse embryonic stem (ES) cell hematopoietic dif-
ferentiation studies facilitated the search for putative
hemangioblast-like cells. ES cells are pluripotent cells
derived from the inner cell mass of the blastocyst [7].
They are characterized by self-renewal ability and the
capacity to recapitulate early embryonic development
by differentiating into cell derivatives of all three
embryonic germ-cell layers [8].
Embryonic stem cells differentiated in hematopoietic
culture conditions for 2.5 days generated blast colony-
forming progenitor cells (BL-CFC), that were able to
give rise to both, hematopoietic and endothelial cells
[9]. The BL-CFC (putative hemangioblast) represents a
transient population that persists for a very short time
in the differentiation culture. It expresses genes com-
mon to both hematopoietic and endothelial lineage,
including Flk1 [10]. More recently it has been shown
Fig. 1. Sites and times of blood cell generation in the mouse embryo. Blood generation in the mouse embryo starts in the blood islands of
extraembryonic yolk sac (YS) at embryonic day 7 (E7) with a transient wave of ‘primitive’ erythrocyte, megakaryocyte and macrophage
production. The erythrocytes and megakaryocytes of that stage are short-lived and disappear by E9. Primitive macrophages are
hypothesized to be the source of tissue resident macrophages in the adult brain. The second wave of blood generation gives rise to
bipotential erythroid-myeloid progenitors (EMPs) that emerge in the YS from E8.25. Shortly thereafter, lymphoid potential in detected. The
paired dorsal aortae contain lymphoid potential as do the allantois/chorion. In the third hematopoietic wave, long-lived transplantable
hematopoietic stem cells (HSCs) are generated beginning at E10.5 in the aorta-gonad mesonephros (AGM) region. HSCs are also detected
in the vitelline (VA) and umbilical (UA) arteries, YS, placenta and in embryonic head. HSCs and EMPs migrate to the fetal liver (FL) where
they expand and reside before migrating to the bone marrow niches.
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that the BL-CFC have an additional differentiation
potential to cardiomyocyte lineage [11] and thus, the
physical isolation of the hemangioblast remains diffi-
cult. Nonetheless, to better understand embryonic
hematopoiesis in vitro ES cell hematopoietic differenti-
ation models have been widely used, as they recapitu-
late the early stages of hematopoietic cell development
and differentiate to almost all hematopoietic lineages,
thus facilitating biochemical analyses of transcription
factors and other regulatory molecules involved in
development.
The earliest blood cells detected in
the embryo are primitive erythrocytes,
macrophages, and megakaryocytes
Blood cells that emerge in the first wave of hematopoi-
etic cell generation are ‘primitive’ erythrocytes, macro-
phages and rare megakaryocyte progenitors [2,12].
This developmental wave is categorized as ‘primitive’
due to the distinctive characteristics of the erythrocytes
and erythrocyte colony-forming unit cells (EryP-CFU-
Cs). ‘Primitive’ red blood cells are nucleated and are
three times larger than fetal and six times larger than
adult erythrocytes [13,14]. Moreover, they produce a
developmentally distinct embryonic (bH1) globin,
which is not detected in adult erythrocytes. ‘Primitive’
erythrocytes peak in numbers at E8.25 and disappear
rapidly by E9 [2,12]. The short developmental time of
these cells resembles the transient nature of heman-
gioblast-like cells, thus supporting the hypothesis that
they originate from a short-lived precursor.
Concurrently, rare macrophage progenitors are
detected in the YS [2,15]. ‘Primitive’ macrophages
from this first YS hematopoietic wave (E7–7.5) are
directly derived from the blood islands and do not go
through a monocyte intermediate [16–18] that charac-
terizes the macrophages generated from HSCs in the
adult bone marrow. Once the bloodstream is estab-
lished at E8.25–8.5 [19] the YS-derived macrophages
migrate to the developing tissues where they become
‘tissue resident’ macrophages expressing high levels of
F4/80 macrophage surface marker. These include
macrophages in the skin, microglia in the brain, Kupf-
fer cells in the liver, and Langerhans cells in the epi-
dermis. Recent lineage-tracing studies suggest that
‘tissue resident’ macrophages in the skin, liver, and
lung are replaced before birth by ‘monocyte derived’
macrophages generated in later waves of hematopoietic
development [20]. In contrast, the labeled brain micro-
glia cells are retained throughout adult life. Unique to
these macrophages, as compared to those in the adult,
are high F4/80 expression, c-Myb transcription factor
independence and PU.1 transcription factor depen-
dence [20–23]. By E9.5, the quantitative abundance of
phenotypic ‘primitive’ macrophages and megakary-
ocytes in the embryo further suggests that these cells
are directly generated in the first hematopoietic wave
and not from the later waves of hematopoietic progen-
itor (HPC) and stem cell generation [15,24].
The need for these early blood cells in the embryo
before the circulation is established is puzzling. ‘Primi-
tive’ erythrocytes may be necessary for providing the
rapidly growing embryo with oxygen, macrophages for
phagocytosis of cells during tissue remodeling and for
lymphatic development but the role of megakaryocytes
is uncertain, although they are closely associated with
red blood cells.
Multipotent progenitors are generated
in the YS during a second wave of
blood cell generation
After the generation of ‘primitive’ erythrocytes, macro-
phages, and megakaryocytes, another wave of
hematopoietic cell production begins at E8.25 in the
YS (Fig. 1). It overlaps temporally with the first wave
[2], but produces functionally more complex bipoten-
tial erythroid–myeloid progenitors (EMP). EMP cells
express high levels of tyrosine receptor kinase ckit
(CD117) and CD41, and by E9.5 are positive for gran-
ulocyte–monocyte marker CD16/32 expression [24].
EMP-derived erythrocytes are distinguished from their
earlier, ‘primitive’ counterpart by the expression of
adult (bmajor) globin [2] and by undergoing enucle-
ation. Thus, based in this complexity and the genera-
tion of adult-like cells this wave is termed ‘definitive’
[25]. However, ckithiCD41+CD16/32+ EMPs lack
lymphoid cell potential, and are able to provide only
short-term in vivo reconstitution, giving rise to mainly
circulating red blood cells [24]. Hence, EMPs are dis-
tinct from HSCs.
Study of Ncx1 null which lack circulation show that
EMPs are generated in the YS and not in the embryo
proper through E9.5 [24,26]. They appear to emerge
from ckit+ cell clusters found in the venous and arte-
rial vessels of the YS [27]. These cells then colonize the
newly forming liver around late E9 [25] give rise to the
large numbers of erythrocytes, macrophages, granulo-
cytes, and monocytes found before the establishment
of a permanent hematopoietic system [20].
Other hematopoietic cells generated in the second
wave are rare cells with lymphoid potential, B-1 B cell
progenitors. They are detected at E8.5/9.5 in the YS
and aorta [28–30]. Mast cells are also found in the YS
from E9.5 onwards [31]. Taken together, this
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‘definitive’ wave of hematopoietic cell generation yields
more adult-like functionally competent blood cell
types. Also, there is growing evidence that these cells
may play an interactive role in promoting the third
wave of hemogenesis and HSC generation [32–34].
HSCs and HPCs emerge by EHT
Adult-type HSCs are defined by their robust ability to
repopulate long term all blood lineages upon trans-
plantation into irradiated adult recipients. In the
mouse embryo, the first adult HSCs appear and are
autonomously generated in the aorta-gonad-mesone-
phros (AGM) region at E10.5 (Fig. 1) [35,36]. They
are also found in the vitelline and umbilical arteries
(VA, UA) and in the head [37,38]. Shortly thereafter,
HSCs are detected in the YS, placenta, circulation and
fetal liver (FL) [35,36,39,40]. Althoughthe YS and pla-
centa may be capable of autonomously generating
HSCs, the FL serves only as a niche for the expansion
of HSCs (and EMPs) made in the other tissues
[39,41,42]. Just before birth, HSCs migrate to the bone
marrow where they reside throughout mammalian
adult life in specialized niches [43].
Hematopoietic stem cells are generated from a sub-
set of embryonic endothelial cells that possess hemo-
genic potential—the hemogenic endothelial cells
(Fig. 2A) [44,45]. They are detected at the time when
clusters of hematopoietic cells appear on the ventral
wall of the dorsal aorta. These intra-aortic hematopoi-
etic cluster cells (IAHC) are ckit+ and at E10.5,
approximately 600 IAHCs (1–19 ckit+ cells per clus-
ter) were found along the length of the embryo by
whole-mount embryo imaging [46]. Figure 2B shows
Gata2 mouse model where Gata2 marks the IAHCs.
The clusters are also found in the YS vasculature
(Fig. 2C). Vital imaging of the mouse embryonic aorta
at the time of HSC generation revealed the transition
of morphologically flat endothelial cells to cells that
bulge out of the vascular wall and form round
hematopoietic cells in the lumen of the aorta. This
process was visualized in Ly6a (Sca1) GFP fluorescent
reporter transgenic embryos. GFP is expressed in all
embryonic and adult HSCs in the mouse
[37,38,40,47,48] and hence, is an excellent reporter for
observing the emergence of HSC. To visualize EHT in
the aorta by confocal time-lapse imaging, thick sec-
tions of Ly6aGFP E10.5 embryos were stained with a
combination of antibodies against hematopoietic and
endothelial cell surface markers [49]. Hemogenic
endothelial cells that give rise to HSCs could be distin-
guished from other aortic endothelial cells by the
expression of GFP. Rare GFP+ckit+CD41+ cells
were observed bulging into the lumen of the aorta
A
C
B
Fig. 2. Emergence of HSCs in the AGM
and in the YS. (A) A subset of aortic
endothelial cells, the hemogenic
endothelial (HE) cells transdifferentiate to
form intra-aortic hematopoietic cluster
cells (IAHC) and hematopoietic stem cells
(HSC). A schematic diagram of a
transverse section through an E10.5
mouse aorta indicates HE, IAHC, and
emerging HSC. (B) Transverse section
through an E10.5 Gata2Venus mouse
embryo. Gata2 is one of the pivotal
transcription factors expressed in HE,
IAHC and emerging HSCs. Thus,
Gata2Venus reporter can be exploited to
visualize the emergence of HSCs.
Section of an E10.5 aorta-gonad-
mesonephros (AGM) shows Gata2 (green)
in most of the CD34+ (red) IAHC
(arrowhead) and some endothelial cells.
Gata2 is also detected in a few round
CD34 cells (asterisk) that are closely
associated with IAHC suggesting that they
arose from clusters. (C) CD34+Gata2+
clusters are also found in the YS
vasculature. Size bars = 20 lm.
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directly from GFP+CD31+ ventral aortic endothelial
cells, thus facilitating the tracking of single cells as
they transition from an endothelial cell to a HSC/
HPC. This process is generally known as the EHT.
Endothelial-to-hematopoietic cell transition has also
been imaged in zebrafish embryos, however, the pro-
cess is slightly different than that observed in mouse
embryos. The hemogenic endothelial cells in zebrafish
bulge ablumenally, and emerge as hematopoietic cells
in the interstitial region between the aorta and axial
vein. Moreover, multicell clusters do not form. Emerg-
ing zebrafish HS/PCs are marked by c-Myb expression
[50]. Vital time-lapse imaging of compound transgenic
c-Myb-GFP:Kdr1 (Flk1 endothelial marker)-mCherry
zebrafish embryos demonstrates that hematopoietic
cells acquiring CD41 expression emerge directly from
endothelium in the ventral side of the dorsal aorta
[51–53]. They move quickly to extravasate into the
lumen of the axial vein where they enter the circula-
tion. They are next found to enter specific niches in
caudal hematopoietic tissue, the equivalent of the
mouse fetal liver [54].
Endothelial-to-hematopoietic cell transition has also
been recapitulated in vitro and detected by time-lapse
imaging of ES cell hematopoietic differentiation cul-
tures. ES cell-derived cells expressing the endothelial
marker Tie2 and ckit, when exposed to hematopoietic
culture conditions, give rise to CD41+ hematopoietic
cells that downregulate Tie2 [55,56]. Together these
data provide in vitro and in vivo morphological and
phenotypical evidence of HSC/HPC emergence via
EHT—a process that is conserved in human ESCs [57]
and all vertebrate embryos [44] thus far examined.
Pivotal regulators of EHT and HSC
generation
Several hematopoietic transcription factors have been
found to play an essential role in the generation of
‘definitive’ hematopoietic cells in the mouse embryo.
As two of the most frequently studied, Gata2 and
Runx1 are the focus of this section. The importance of
these factors in the process of HS/PC generation was
first highlighted by the creation of germline knockout
mice. Gata2 and Runx1 homozygous deletions resulted
in embryonic lethality at E10.5 and E12.5, respectively,
accompanied by severe fetal liver anemia [58,59].
Functional studies revealed that although Runx1/
mice make ‘primitive’ hematopoietic cells, they com-
pletely lack ‘definitive’ hematopoietic progenitors in
the YS and fetal liver and importantly, no HSCs are
generated in the AGM [59,60]. Similarly, the Gata2/
embryos are defective for ‘definitive’ hematopoiesis, as
demonstrated by greatly reduced progenitor numbers
[58,61]. Recently it was demonstrated by using a
Gata2Venus reporter mouse model that Gata2 is
expressed in all functional HSCs, and in most HPCs
[62]. In vitro hematopoietic differentiation experiments
with Gata2/ and Runx1/ ES cells show that they
retain the ability to undergo ‘primitive’ erythroid dif-
ferentiation, however, at reduced levels. ‘Definitive’
hematopoietic progenitor generation is profoundly
impaired. Analysis of ES cell-generated Gata2/ and
Runx1/ chimeric mice revealed a lack of knockout
cell contribution to any of the hematopoietic organs
[58,59]. Thus, Gata2 and Runx1 play pivotal roles in
hematopoietic development, affecting mainly the
‘definitive’ stage in which HPCs and HSCs are gener-
ated.
The temporal and spatial expression patterns of
Runx1 and Gata2 in the embryo (as determined by
in situ hybridization, immunostaining, and/or knockin/
transgenic reporters) support their important cell-
intrinsic role in HSC and HPC generation. These fac-
tors are expressed at E8.0 in the YS, which at that
time is the main site of hematopoietic cell (EMP) gen-
eration [62–65]. Slightly thereafter, from E8.5 to E11.5
Runx1 marks the endothelial cells on the ventral side
of the aorta, umbilical and vitelline arteries, placenta,
and head [38,63,66,67]. Although Gata2 is expressed in
the endothelial cells lining the aorta already at E8.5,
the frequency of cells expressing Gata2 increases in the
AGM and FL concurrent with the emergence of
IAHC and the first HSCs [62]. It is also expressed in
the vitelline and umbilical arteries and the placenta.
Moreover, both Gata2 and Runx1 are expressed in
IAHCs in the embryonic arteries and all such
hematopoietic clusters are absent in the aortae and
other major arteries of Gata2/ and Runx1/
embryos [63,68–71].
The continuum of expression during the transition
from endothelial cells to hematopoietic cluster cells in
static images of the aorta implicates these factors in
the process of EHT. Indeed, conditional deletion of
Gata2 and Runx1 in hemogenic endothelium marked
by vascular endothelial-cadherin (Vec) expression or
Tie2 expression demonstrates that these factors are
essential in the hemogenic endothelial cells for the for-
mation of hematopoietic clusters and importantly, for
the generation of functional HPCs and HSCs
[47,71,72]. Moreover, Runx1 is required for HSC gen-
eration between E10.5 and E11.5, as shown by tamox-
ifen-induced deletion in Vec-expressing cells [73]. The
vital imaging of Runx1 morphant zebrafish embryos
provided an interesting insight into its role. In the
absence of Runx1, aortic endothelial cells undergo
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sudden death as they attempt transition to hematopoi-
etic cells, thus suggesting that Runx1 is required during
EHT for the survival of emerging hematopoietic cells
[51].
To test whether Runx1 and Gata2 are required in
hematopoietic cells after they are generated in the
mouse embryo, conditional deletion was performed in
cells marked by Vav expression. Although Runx1 is
not required [70], Gata2 continues to be essential in
the HSCs after they are made [71]. Therefore, Gata2
and Runx1 are pivotal to HSC and HPC emergence in
EHT during embryonic development, but are differen-
tially required as hematopoietic development proceeds.
Gata2 and Runx1 levels are strictly
controlled in EHT
It is of importance to note that HSC and HPC devel-
opment is highly dependent on the levels of Runx1
and Gata2 expression. Gata2+/ embryos have pro-
foundly reduced numbers of AGM HSCs, HPCs and
IAHCs. The bone marrow of Gata2+/ adult mice
contains normal quantities of HSCs, but these are
qualitatively impaired, as observed in competitive
transplantation assays [61,71,74]. Overexpression of
Gata2 also results in abnormal hematopoiesis: it
reduces bone marrow colony-forming unit-cell (CFU-
C) and colony-forming unit-spleen (CFU-S) activity
and results in a failure of multilineage reconstitution
[75]. Hematopoietic differentiation of ES cells overex-
pressing Gata2 suggests that abnormally high Gata2
expression blocks T- and B-cell generation, resulting in
myeloid-biased cell production [76,77]. Thus, Gata2
expression levels are likely to be involved in control-
ling cell fate decisions. Recent transcriptome analysis
of placental cells suggests that Gata2 is continuously
expressed in hemogenic and hematopoietic progenitors,
but downregulated during commitment to blood lin-
eages [78]. Also, Gata2 expression is downregulated
during ES cell-derived hemangioblast differentiation
into blast cells [79], thus indicating that levels of Gata2
may play a role in HSC and HPC expansion and
potency.
Runx1 also functions in a dose-dependent manner.
Runx1+/ embryos generate fewer HPCs and HSCs
[60,80–82]. Fascinatingly, Runx1+/ embryos experi-
ence a temporal shift in the emergence of HSCs. HSCs
are detected earlier than normal: at E10 in the AGM
and YS, and HSC activity is prematurely terminated
in the E11 AGM [60]. The E10.5/11.5 aorta in
Runx1+/ embryos has fewer IAHCs, suggesting that
Runx1 haploinsufficiency reduces HSC generation,
maintenance, and/or proliferation. Thus, normal
diploid levels of Runx1 are essential during develop-
ment for the timely emergence of HSCs and HPCs.
Gata2 and Runx1 function
synergistically to regulate their
downstream targets
Although deletion of a single Gata2 or Runx1 allele
disrupts HSC and HPC development, it does not result
in embryonic lethality [58,60,63]. Strikingly, the analy-
sis of Gata2+/: Runx1+/ compound embryos
showed a trend toward fewer hematopoietic progeni-
tors and the absence of double haploinsufficient off-
spring due to embryonic lethality [83]. These data
suggest that Gata2 and Runx1 function together in the
same cells to control the expression of hematopoietic
genes involved in HSC and progenitor cell generation.
Further evidence for combinatorial function of
Gata2 and Runx1 comes from an extensive ChIP-seq
and bioinformatics analysis revealing interaction com-
plexes between a heptad of hematopoietic cell-specific
transcription factors that includes Runx1 and Gata2.
The vast majority of heptad-bound promoter and
enhancer regions of hematopoietic genes contain a
GATA consensus binding sequence. Only approxi-
mately 40% of them contain a Runx consensus bind-
ing motif, suggesting that Runx1 recruitment to the
regulatory elements within the complex is mediated by
Gata2 [83]. Combinatorial interactions within the hep-
tad complex result in hematopoietic cell type-specific
chromatin binding and downstream gene expression.
How exactly the complex functions in cell fate specifi-
cation, is yet unknown. Whether the factors act
sequentially or all at the same time, whether they regu-
late each other and how individual factor levels affect
complex formation is a matter of debate.
RNA sequencing of endothelial cells, hemogenic
endothelial cells, HPCs, and HSCs in the AGM show
that heptad transcription factor expression is increas-
ing during EHT, and is accompanied by transcrip-
tional activation of several downstream target genes.
One such target gene is the G protein-coupled receptor
56 (Gpr56) that is significantly upregulated (38-fold) in
HSCs as compared with hemogenic endothelial cells
[84]. Notably, Gpr56 expression is downregulated as a
result of Gata2 (regulatory element) deletion, which is
accompanied by severe disruption of hematopoiesis
and embryonic lethality [75]. Moreover, ChIP experi-
ments reveal direct binding of Gata2 to the Gpr56 +37
enhancer, [84,85] thus indicating that Gpr56 is a direct
target of Gata2. The precise function of Gpr56 in
hematopoiesis is as yet unknown. It has been sug-
gested to play a role in the maintenance of self-renewal
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[84], and it is essential for HSC repopulation potential
in mice [86]. In zebrafish, Gpr56 is required for the
emergence of hematopoietic cells in the dorsal aorta,
[84] thereby supporting its functional involvement in
EHT.
Another means by which the heptad complex may
regulate HSC and HPC emergence is by inducing a
stepwise expression of transcriptional suppressors Gfi1
and Gfi1b—the direct targets of Runx1. The expression
of these transcription factors in hemogenic endothe-
lium is pivotal for the normal EHT transition. Time-
lapse imaging of Gfi1+ cells show that they acquire
Gfi1b expression in the IAHCs followed by upregula-
tion of ckit and CD41 expression, indicating
hematopoietic commitment. Gfi1: Gfi1b double knock-
out embryos lack IAHCs, and ckit+ cells stay embed-
ded in the endothelial lining of the dorsal aorta
sustaining their endothelial program (Vec and Tie2
expression). Thus, Runx1 together with Gfi1 factors
promote EHT by suppressing endothelial pro-
gram, thereby allowing hematopoietic cells to emerge
[87–89].
Do HSCs establish their fate prior to
or during EHT?
Vital imaging demonstrates that HSCs and HPCs are
generated by morphological transdifferentiation of spe-
cialized endothelial cells, and genetic tracing studies
show that functional HSCs/HPCs descend from cells
expressing endothelial markers. But when is
hematopoietic fate, and more precisely, when is HSC
fate established? Current research interests are address-
ing the issue of whether HSC fate and function is
determined in the endothelium during EHT, or primed
earlier or later in development.
A Runx1 + 23 enhancer GFP (+23GFP) reporter
mouse was used to explore this issue. Runx1 expression
in vast majority of mouse hematopoietic stem and pro-
genitor cells and aortic endothelial cells is controlled by
a Runx1 + 23 enhancer, thus the +23GFP mouse
model allows specific isolation of hemogenic endothe-
lial cells [90,91]. Transcription analysis (Fluidigm) with
a panel of endothelial and hematopoietic genes demon-
strated that at E8.5 the +23GFP expressing aortic
hemogenic endothelium is distinguished from +23GFP
negative endothelium by higher expression of
hematopoietic regulators such as Meis1, Gata2, Gata3
and SCL. Single-cell transcriptome analysis showed in
approximately 50% of +23GFP hemogenic endothelial
cells that higher Meis1 expression is accompanied by
downregulation of the endothelial marker Etv2, thus
arguing for hematopoietic fate establishment earlier
than previously recognized [91]. At a later developmen-
tal time (at E10.5) in the Ly6a GFP model, the tran-
scriptome of the aortic hemogenic endothelial fraction
(CD31+ckitGFP+) showed differences to the
endothelial fraction (CD31+ckitGFP), with heptad
transcription factor and Notch gene expression
increased [84]. Few indications of hematopoietic gene
expression were found in the hemogenic endothelial
fraction as compared to the HPC/HSC fraction
(CD31+ckit+GFP+). However, these experiments were
performed with populations of sorted cells and await
single-cell transcriptomic analysis. Importantly, the
expression of the heptad factors is the first and pivotal
step directing a hematopoietic program, and as such
Runx1 +23GFP is an excellent indicator showing that
the hemogenic and hematopoietic programs are estab-
lished already in a subset of endothelial cells at the
beginning stage of ‘definitive’ hematopoietic cell devel-
opment.
If hematopoietic and HSC commitment occurs ear-
lier than functional HSCs emerge, the aortic endothe-
lium may harbor immature cells that in the proper
microenvironment are able to mature into functional
HSCs. To test this, an OP9 stromal cell coaggregation
culture was established that facilitates the ex vivo mat-
uration of hematopoietic/endothelial cells obtained by
multisurface marker phenotypic sorting [92]. Using this
approach it was shown that E9.5 dorsal aorta contains
a VEC+CD41+CD45CD43 cell population (termed
pro-HSC) that lacks repopulating activity in direct
in vivo transplantation assays. However, when co-
aggregated with OP9 and ex vivo cultured for 7 days,
this population is able to reconstitute the hematopoi-
etic system of the recipient [93]. These pro-HSCs are
almost devoid of endothelial cells and it is thought
that they may represent a stage directly downstream of
the Runx1 +23GFP+ hemogenic endothelium present
in the E8.5 AGM [91].
Also, the E10.5 and E11.5 AGM is thought to
contain immature HSCs—this VEC+CD41low
CD45CD43+ population (termed pre-HSC) upregu-
lates CD45 expression when coaggregated with OP9
and mature into functional, repopulating HSCs [92].
Interestingly, it has been proposed that the pre-HSCs
may be generated independently of Runx1, as a devel-
opmental block is not observed before the transition
of CD41+ cells to CD45+ in Runx1-deficient mice
[94]. Cells with a pre-HSC phenotype are present also
in the E11.5 YS and FL, but they are not able to
mature into engrafting HSCs. Thus, functional pre-
HSCs are thought to be present mainly in the AGM
region and in the extraembryonic arteries
[92,93,95,96].
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These data propose that definitive HSCs may be
primed for a hematopoietic gene expression program
very early in development, making the precise tempo-
ral onset of the HSC program debatable. However, it
should be taken into account that ex vivo manipula-
tions, such as stromal cell and explant (co-)cultures,
consequently introduce new variables into the model,
that might not be present in in vivo. Advances in
in vivo lineage and vital imaging tracing tools and sin-
gle cell transcriptomics will assist in further investiga-
tions of such cells under more physiologic conditions
representative of the in vivo embryonic milieu.
Recent studies have suggested that mouse embry-
onic head produces adult HSCs and HPCs indepen-
dently from other hematopoietic organs and
circulation. Lineage-tracing experiments show that
embryonic head-derived HSC progeny contribute to
the adult HSC population [38]. However, to date, it
has not been demonstrated that the head HSCs are
emerging via an EHT in a similar manner to those in
AGM. Moreover, the head vasculature lacks IAHCs
[66,97]. Also, head HSCs do not seem to go through
the putative pre-HSC state since no/few pre-HCSs
have been reported in the head as demonstrated by
OP9 coaggregation culture of E11.5 head region [98].
These studies suggest that there may be an alternative
way by which functional HSCs are generated, and
could include generation in different spatial and tem-
poral frameworks, and different regulatory programs
and networks. Defining such mechanisms could con-
tribute to answering questions currently arising in the
field of hematopoiesis: for instance, such information
may clarify the source of heterogeneity among HSCs
—BMP-activated and BMP-nonactivated, myeloid or
lymphoid biased [99,100]. Also, it may provide insight
into why there are many more HPCs in the IAHCs
than HSCs [96], and explain the source of the large
cohort of FL HSCs that appears within 24 h follow-
ing the generation of the first HSCs in the AGM and
the rapid decrease in the pre-HSC numbers in the
AGM [98].
Concluding remarks
The adult hematopoietic system is established through
the progressive generation of hematopoietic cells with
increasing functional complexity, culminating in the
de novo generation of long-lived self-renewing HSCs
that provide the adult organism with all functional
blood cells. Although the precise temporal onset of
expression and of the HSC program and initiation of
function is debatable, it is certain that it is directed by
the expression of a small set of pivotal hematopoietic
transcription factors. In combination, these factors cre-
ate a highly complex network that, depending on the
time and levels of expression, drive the determination
of hematopoietic progenitors and stem cell fate. It
remains a future challenge to determine all the players
in this process, to examine all the precursors to HSCs,
as well as to cells along the process of endothelial-to-
hematopoietic transition on the single-cell level to con-
verge transcriptomics with cell biology and function.
This would ultimately enable the recapitulation of
physiologic HSC development in vitro for the de novo
production of transplantable HSCs for therapeutic
strategies.
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